proteínas del punto de control inmunitario

lmmune checkpoint proteins are key regulators of immune response against threats while preserving self-tolerance. The classic immune checkpoint consists of co-inhibitory receptors (CTLA-4, PD-1, TIGIT, LAG-3), which inhibit T-cell function and co-stimulatory receptors (GITR, 4-1BB, OX40, CD40) which stimulate T cell activation. Research on the co-inhibitory receptor CTLA-4 (cytotoxic T-lymphocyte antigen 4) and PD-1 (programmed cell death protein 1) showed significantly improved survival rates of patients with metastatic solid tumors after inhibition of these receptor pathways. Therefore, antibody drugs against immune checkpoints for cancer, tumors and other diseases therapeutics is a key mode in cancer therapy.


Descubra cómo las proteínas del punto de control inmunitario ayudan al desarrollo de fármacos


Vías del punto de control inmunitario

CD155 ICOSL CD86 CD80 MHC CD40 PD-L2 PD-L1 4-1BBL OX40L GITRL MHC PD-L1 Galectin 9 TIGIT ICOS CTLA-4 CD28 TCR CD40L PD-1 PD-1 4-1BB OX40 GITR TCR PD-1 TIM-3 TCR PD-1 PD-1 LAG-3 MHC PD-L1 PD-L2 MHC-LL Dendritic cell Tumor cell T-cells Macrophage

Haga clic en el nombre de la molécula para ver los detalles del producto

Stimulatory signal

Inhibitory signal

Click to learn more immune checkpoint molecules

Características del producto y aplicaciones

Características del producto:
Alta pureza verificada por MALS o HPLCAlta bioactividad verificada por ELISA/SPR/FACS, etc.Alta consistencia de lote a lote por estricto control de calidad probado
Aplicaciones principales:

Lista de Productos

  • Receptores coinhibidores
  • Receptores coestimuladores
  • Otros

Receptores coinhibidores

Moléculas Etiquetas Tags Conjugados Características
(Protocolos disponibles)
PD-1 Human, Mouse, Canine, Cynomolgus, Rabbit, Rat, Rhesus macaque Fc, His, Fc & His, Fc & Avi & His, Fc & Avi, His & Avi, mFc& Avi, Twin-Strep, Llama Fc , mFc Biotin-labeled, PE-labeled, Unconjugated SDS-PAGE, MALS, HPLC, ELISA, BLI, SPR, FACS
PD-L1 Human, Mouse, Rabbit, Canine, Cynomolgus / Rhesus macaque Fc, His, Fc & Avi, His & Avi, Fc & Avi & His, mFc, LlamaFc, mFc& Avi, Twin-Strep Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, BLI, SPR, FACS
PD-L2 Human, Mouse Fc, His, Fc & Avi, Avi & His, mFc Biotin-labeled, Unconjugated SDS-PAGE, HPLC, ELISA, SPR, BLI, FACS, Cell based assay
B7-H3 Human, Mouse, Cynomolgus Fc & Avi, Avi & His, His, Fc, Avi & His Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, Cell based assay
B7-H4 Human, Mouse His, Fc Biotin-labeled, Unconjugated SDS-PAGE, ELISA
B7-H5 Human, Mouse, Rhesus macaque Fc & Avi, Avi & His, His, Fc, mFc Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, SPR, BLI
BTLA Human, Mouse Fc & Avi, His & Avi, His, mFc, Fc Biotin-labeled, Unconjugated SDS-PAGE, ELISA
CD80(B7-1) Human, Mouse, Cynomolgus / Rhesus macaque Fc, Fc & Avi, Avi & His, mFc, His Biotin-labeled, Unconjugated SDS-PAGE, MALS, HPLC, ELISA, SPR, BLI, FACS
CD86(B7-2) Human, Mouse, Cynomolgus / Rhesus macaque Fc & Avi, Fc, His Biotin-labeled, Unconjugated SDS-PAGE, MALS, HPLC, ELISA, BLI, FACS
CD96 Human His & Avi, His, mFc Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, BLI, FACS
CD47 Human, Mouse, Rabbit, Rat, Cynomolgus / Rhesus macaque, Canine Fc, His, Fc & Avi, His & Avi, mFc, mFc & Avi, LlamaFc Biotin-labeled, FITC-labeled, Unconjugated SDS-PAGE, MALS, ELISA, SPR, BLI, FACS
CD155 Human, Mouse, Rhesus macaque Fc & Avi, His & Avi, mFc, Fc, His Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, BLI, FACS
CTLA-4 Human, Mouse, Rabbit, Rat, Cynomolgus / Rhesus macaque Fc, His, Fc & Avi, His & Avi, mFc, mFc& Avi Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, SPR, BLI, FACS
LAG-3 Human, Mouse, Rat, Cynomolgus, Marmoset Fc, His, Fc & Avi, His & Avi, mFc, mFc & Avi, LlamaFc Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, SPR, BLI, FACS
TIGIT Human, Mouse, Rabbit, Rat, Cynomolgus / Rhesus macaque, Canine mFc& Avi, Fc & Avi, His & Avi, His, Fc, mFc Biotin-labeled, Unconjugated SDS-PAGE, MALS, HPLC, ELISA, SPR, BLI
TIM-3 Human, Mouse, Cynomolgus Avi & His, mFc, Fc, His Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, SPR
CD111 Human His, Fc Unconjugated SDS-PAGE, ELISA, BLI
DNAM-1 Human, Cynomolgus Fc & Avi, His, Fc Biotin-labeled, Unconjugated SDS-PAGE, ELISA, BLI, FACS
Galectin-9 Human His, MBP & His Unconjugated SDS-PAGE
HVEM Human His, Twin-Strep, Fc, mFc, Fc & Avi Biotin-labeled, Unconjugated , SDS-PAGE, ELISA, BLI
Nectin-2 Human His, Fc Biotin-labeled, Unconjugated SDS-PAGE, HPLC, ELISA, BLI
Nectin-3 Human His, Fc Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, BLI
PVRIG Human, Mouse, Cynomolgus Fc & Avi, mFc& Avi, His & Avi, His, mFc Biotin-labeled, Unconjugated SDS-PAGE, MALS, ELISA, BLI
SIRP alpha Human, Mouse, Cynomolgus Fc, His & Avi, mFc& Avi, mFc, His Biotin-labeled, PE-labeled, Unconjugated SDS-PAGE, MALS, HPLC, ELISA, BLI, FACS
SIRP alpha V2 Human His Biotin-labeled, Unconjugated SDS-PAGE, ELISA
SIRP gamma Human Fc Unconjugated SDS-PAGE, ELISA
CD160 Human His Unconjugated SDS-PAGE, ELISA

Kits de detección de inhibidores

Productos relacionados

Características claves

Estructura auténtica verificada por SEC-MALS

CD27 Ligand, MALS-validated protein

Figure 1. The purity of Human CD27 Ligand, His,Flag Tag (active trimer) (MALS verified) (Cat. No. CDL-H52Da) is more than 95% in HP-SEC, and around 55-70 kDa verified by SEC-MALS.

Alta consistencia de lote a lote

The consistency in purity and bioactivity is essential for recombinant proteins.All our proteins have to pass a variety of purity and bioactivity assessments.

PD-1, MALS-validated protein

Biotinylated Human PD-1 / PDCD1 Protein, Avitag™,His Tag (recommended for biopanning) (MALS verified)(Cat. No. PD1-H82E4

Aplicación 1: Desarrollo y cribado de fármacos de anticuerpos

Antibody binding assay

PD-1&PD-L1 pathway

PD-1, MALS-validated protein1

Immobilized Human PD-1, His Tag (Cat. No. PD1-H5221) at 2 μg/mL (100 μL/well) can bind anti-PD-1 mab with a linear range of 0.1-3 ng/mL (Routinely tested).

PD-1&PD-L1 pathway

PD-1, MALS-validated protein2

Serial dilutions of anti-PD-1 mab were added into Human PD-1, Fc Tag, low endotoxin (Cat. No. PD1-H5257): Biotinylated Human PD-L1, Fc, Avitag, His Tag (Cat. No. PD1-H82F3) binding reactions. The half maximal inhibitory concentration (IC50) is 0.5381 μg/mL (Routinely tested).

In addition, ACROBiosystems have also developed PD1: PD-L1 (Cat. No. EP-101) and CD47: SIRP alpha (Cat. No. EP-102) inhibitor screening assay kits that can screen neutralizing antibodies or small molecules with high throughput.

Learn more about inhibitor screening kit

Antibody drug affinity assay

LAG-3 pathway

LAG-3, BLI-validated protein

Loaded Anti-LAG-3 MAb (Human IgG1) on AHC Biosensor, can bind Human LAG-3, His Tag (Cat. No. LA3-H5222) with an affinity constant of 7.47 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

LAG-3 pathway

LAG-3, SPR-validated protein

Anti-LAG-3 MAb (Human IgG1) captured on CM5 chip via Anti-Human IgG Fc antibodies surface, can bind Human LAG-3, His Tag (Cat. No. LA3-H5222) with an affinity constant of 4.57 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Neutralizing antibody binding assay

TIGIT pathway

TIGIT, MALS-validated protein

Serial dilutions of Human TIGIT Neutralizing antibody were added into Human TIGIT, Fc Tag (Cat. No. TIT-H5254): Biotinylated Human CD155, Fc,Avitag (Cat. No. CD5-H82F6) binding reactions. The half maximal inhibitory concentration (IC50) is 0.55834 μg/mL (Routinely tested).

CD47&SIPR α pathway(Cell-based assay)

CD47, FACS-validated protein

FACS analysis shows that the binding of Human CD47 to ACHN expressing SIRP-a was inhibited by increasing concentration of neutralizing SIRP-a antibody. The concentration of Human CD47 used is 20 μg/mL. IC50=9.334 μg/mL

Ensayo basado en células

4-1BB pathway

4-1BB Ligand, Cell-based assay validated protein

Human 4-1BB Ligand (71-254) Protein, Fc Tag, premium grade (Cat. No. 41L-H5269) induce IL‐8 secretion in HT1080 human CD137 cell line. The specific activity of Human 4-1BB Ligand (71-254) Protein, Fc Tag, premium grade is>1.00*10^5 U/mg (QC tested).


Análisis de farmacocinética (PK)

CTLA-4 pathway

CTLA-4 dimer, Cell-based assay validated protein

Immobilized Human CTLA-4, His Tag, active dimer (Cat. No. CT4-H52H9) at 2 μg/mL, add increasing concentrations of CTLA-4 x OX40 Bispecific Antibody in 50% Human serum and then add Biotinylated Human OX40, Avitag, His Tag(Cat. No. TN4-H82E4) at 1 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 4 ng/mL (Intact assay, Routinely tested).

Reference

  • Antecedente
  • Vías del punto de control inmunitario
  • Características del producto y aplicaciones
  • Lista de Productos
  • Kits de detección de inhibidores
  • Productos relacionados
  • Características claves
  • Reference